HR
TMDX icon

Howe & Rusling’s Transmedics TMDX Stock Holding History

Howe & Rusling’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,000
Closed -$83K – 967
2022
Q3 		$83K Hold
2,000
– – 0.01% 280
2022
Q2 		$63K Hold
2,000
– – 0.01% 289
2022
Q1 		$54K Hold
2,000
– – 0.01% 313
2021
Q4 		$38K Hold
2,000
– – ﹤0.01% 351
2021
Q3 		$66K Hold
2,000
– – 0.01% 283
2021
Q2 		$66K Hold
2,000
– – 0.01% 273
2021
Q1 		$83K Hold
2,000
– – 0.01% 255
2020
Q4 		$40K Hold
2,000
– – 0.01% 303
2020
Q3 		$28K Buy
+2,000
New +$34.3K ﹤0.01% 322

Other funds holding TMDX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCP
Sandhill Capital Partners Buffalo, New York $1.23B AUM 13.7% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
SPPAM
Summit Partners Public Asset Management Boston, Massachusetts $5.69B AUM 259.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Howe & Rusling's TMDX Position: Q4 2022 in Review

Howe & Rusling sold out of Transmedics (TMDX) in Q4 2022, closing a stake of 2,000 shares — an estimated $83K sold.

Howe & Rusling first reported a position in TMDX in Q3 2020 and held it in 9 quarters. The position peaked at $83K in Q3 2022. 199 funds tracked by Wall St. Rank hold TMDX as of Q4 2022.

  • Howe & Rusling reported no remaining Transmedics position as of Q4 2022 after selling out during the quarter.
  • Howe & Rusling sold 2,000 Transmedics shares in Q4 2022, an estimated $83K.
  • Howe & Rusling first reported a position in Transmedics in Q3 2020 and held it in 9 quarters.
  • Howe & Rusling's Transmedics position peaked at $83K in Q3 2022.
  • 199 funds tracked by Wall St. Rank held Transmedics as of Q4 2022.

Based on Howe & Rusling's 13F filing for Q4 2022, filed 15 Feb 2023.